2026 QTAS Intern - Bispecific Antibody Stability for In Vivo Studies (PhD) jobs in United States
cer-icon
Apply on Employer Site
company-logo

AbbVie · 4 hours ago

2026 QTAS Intern - Bispecific Antibody Stability for In Vivo Studies (PhD)

positionSouth San Francisco, CA
timeInternship
remoteOnsite
seniorityIntern
workcardStart in 2026 Summer

AbbVie is a company dedicated to discovering and delivering innovative medicines and solutions that address serious health issues. The intern will work in the Biologics Bioanalysis Characterization and Proteomics group, focusing on evaluating the stability of bispecific antibodies using in vivo PK/TK study samples and comparing quantification methods.

BiotechnologyFinancial ServicesHealth CareMedicalPharmaceuticalVenture Capital
check
Comp. & Benefits
check
H1B Sponsor Likelynote

Responsibilities

Familiarize with key lab instruments, including Bravo AssayMAP, Sciex Triple quad 7500, and Bruker maXis II qTOF
Operate lab instruments by following historical protocols with used samples
Complete online training sessions and develop an understanding of project planning
Quantify variable regions using surrogate peptides for each chain with MRM on Sciex 7500 utilizing in vivo samples
Quantify antibodies at intact level or subunits on Bruker qTOF with in vivo samples
Analyze quantitative data using MultiQuant, PMI Byos and Prism software
Present the study findings at an internal poster/ oral presentation session

Qualification

Protein mass spectrometryLC-MS analysisHigh-resolution mass spectrometryMicrosoft OfficeCommunication skills

Required

Currently enrolled in university, pursuing a PhD in Chemistry, Chemical Biology, Pharmaceutical Sciences, Biophysics, or other related field
Must be enrolled in university for at least one semester following the internship
Good understanding of protein mass spectrometry
Hands-on experience of LC-MS analysis
Use Microsoft Office Excel, Word and PowerPoint
Good written and verbal communication skills

Preferred

Expected graduation date between December 2026 – June 2027
Exposure to protein bioanalysis with LC-MS
Hands-on experience of LC-MS analysis on Triple-quad and qTOF mass spectrometers
Hands-on experience of protein affinity purification

Benefits

Competitive pay
Relocation support for eligible students
Select wellness benefits and paid holiday / sick time

Company

AbbVie

twittertwittertwitter
Glassdoor3.9
company-logo
AbbVie is a biopharmaceutical company focused on immunology, oncology, neuroscience, virology, and aesthetics. It is a sub-organization of AbbVie.
dateFounded in 2013
location
North Chicago, Illinois, USA
people-size10001+ employees
web-link
https://www.abbvie.com

H1B Sponsorship

AbbVie has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (273)
2024 (190)
2023 (225)
2022 (284)
2021 (186)
2020 (186)

Funding

Current Stage
Public Company
Total Funding
$15B
2024-02-27Post Ipo Debt· $15B
2023-03-08Post Ipo Equity· $0.25M
2012-12-20IPO

Leadership Team

leader-logo
Robert Michael
Chairman of the Board and Chief Executive Officer
linkedin
leader-logo
Micah Bregman
Vice President, Global Strategy and Pipeline, Allergan Aesthetics
linkedin

Recent News

TradingView
Key facts: AbbVie to invest $100B in U.S. research; Phase 3 trial shows progress
2026-01-18
FiercePharma
JPM26, Day 3: AbbVie touts 'clear line of sight' to continued growth into 2030s
2026-01-17
FiercePharma
Fierce Pharma Asia—AbbVie’s bispecific play, Illumina’s China import efforts and pharma execs’ JPM comments
2026-01-17
Company data provided by crunchbase